Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Vascular proliferation is a prognostic factor in breast cancer.

Arnes JB, Stefansson IM, Straume O, Baak JP, Lønning PE, Foulkes WD, Akslen LA.

Breast Cancer Res Treat. 2012 Jun;133(2):501-10. doi: 10.1007/s10549-011-1785-7.

PMID:
21947750
2.

Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer.

Krüger K, Stefansson IM, Collett K, Arnes JB, Aas T, Akslen LA.

Breast. 2013 Jun;22(3):282-8. doi: 10.1016/j.breast.2012.07.008.

PMID:
22840462
3.

HOXB9 expression promoting tumor cell proliferation and angiogenesis is associated with clinical outcomes in breast cancer patients.

Seki H, Hayashida T, Jinno H, Hirose S, Sakata M, Takahashi M, Maheswaran S, Mukai M, Kitagawa Y.

Ann Surg Oncol. 2012 Jun;19(6):1831-40. doi: 10.1245/s10434-012-2295-5.

PMID:
22396001
4.

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.

Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G.

J Natl Cancer Inst. 1992 Dec 16;84(24):1875-87.

PMID:
1281237
5.

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.

Gasparini G, Toi M, Gion M, Verderio P, Dittadi R, Hanatani M, Matsubara I, Vinante O, Bonoldi E, Boracchi P, Gatti C, Suzuki H, Tominaga T.

J Natl Cancer Inst. 1997 Jan 15;89(2):139-47.

PMID:
8998183
6.

Vascular proliferation is increased in basal-like breast cancer.

Nalwoga H, Arnes JB, Stefansson IM, Wabinga H, Foulkes WD, Akslen LA.

Breast Cancer Res Treat. 2011 Dec;130(3):1063-71. doi: 10.1007/s10549-011-1740-7.

PMID:
21874512
7.

Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.

Heimann R, Ferguson D, Powers C, Recant WM, Weichselbaum RR, Hellman S.

J Natl Cancer Inst. 1996 Dec 4;88(23):1764-9.

PMID:
8944007
8.

Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients.

Gasparini G, Toi M, Verderio P, Ranieri G, Dante S, Bonoldi E, Boracchi P, Fanelli M, Tominaga T.

Int J Oncol. 1998 May;12(5):1117-25.

PMID:
9538138
9.

Tumor angiogenesis in node-negative breast carcinomas--relationship with epidermal growth factor receptor, estrogen receptor, and survival.

Fox SB, Leek RD, Smith K, Hollyer J, Greenall M, Harris AL.

Breast Cancer Res Treat. 1994 Jan;29(1):109-16.

PMID:
7517221
10.

Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.

Axelsson K, Ljung BM, Moore DH 2nd, Thor AD, Chew KL, Edgerton SM, Smith HS, Mayall BH.

J Natl Cancer Inst. 1995 Jul 5;87(13):997-1008.

PMID:
7543156
11.

Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis.

Bochner BH, Cote RJ, Weidner N, Groshen S, Chen SC, Skinner DG, Nichols PW.

J Natl Cancer Inst. 1995 Nov 1;87(21):1603-12.

PMID:
7563203
12.

Evaluation of protein pigment epithelium-derived factor (PEDF) and microvessel density (MVD) as prognostic indicators in breast cancer.

Zhou D, Cheng SQ, Ji HF, Wang JS, Xu HT, Zhang GQ, Pang D.

J Cancer Res Clin Oncol. 2010 Nov;136(11):1719-27. doi: 10.1007/s00432-010-0830-y.

PMID:
20229034
13.

Prognostic value of vascular density and cell proliferation in breast cancer patients.

Tynninen O, von Boguslawski K, Aronen HJ, Paavonen T.

Pathol Res Pract. 1999;195(1):31-7.

PMID:
10048092
14.
15.

Vascular grading of angiogenesis: prognostic significance in breast cancer.

Hansen S, Grabau DA, Sørensen FB, Bak M, Vach W, Rose C.

Br J Cancer. 2000 Jan;82(2):339-47.

16.

Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer.

Kato T, Kameoka S, Kimura T, Soga N, Abe Y, Nishikawa T, Kobayashi M.

Breast Cancer Res Treat. 2001 Nov;70(1):65-74.

PMID:
11767005
17.
18.

Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study.

Fontanini G, Lucchi M, Vignati S, Mussi A, Ciardiello F, De Laurentiis M, De Placido S, Basolo F, Angeletti CA, Bevilacqua G.

J Natl Cancer Inst. 1997 Jun 18;89(12):881-6.

PMID:
9196255
19.

Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients.

Fox SB, Leek RD, Bliss J, Mansi JL, Gusterson B, Gatter KC, Harris AL.

J Natl Cancer Inst. 1997 Jul 16;89(14):1044-9.

PMID:
9230886
20.

Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients.

Ludovini V, Sidoni A, Pistola L, Bellezza G, De Angelis V, Gori S, Mosconi AM, Bisagni G, Cherubini R, Bian AR, Rodinò C, Sabbatini R, Mazzocchi B, Bucciarelli E, Tonato M, Colozza M.

Breast Cancer Res Treat. 2003 Sep;81(2):159-68.

PMID:
14572158

Supplemental Content

Support Center